📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer. (2023)

First Author: Halford S
Attributed to:  MICA: The Newcastle Proximity Laboratory funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-22-2263

PubMed Identifier: 36652553

Publication URI: http://europepmc.org/abstract/MED/36652553

Type: Journal Article/Review

Volume: 29

Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research

Issue: 8

ISSN: 1078-0432